On April 3, 2023, BioCorRx Inc. closed the transaction. The company issued 171,296 shares for proceeds of $300,000 as well as a warrant to purchase 171,296 shares in its second and final tranche. The round included participation from Louis C Lucido and Carolyn M. Lucido.